[1] MALDONADO L L,ASSIS J,ARAÚJO F M,et al.The Echinococcus canadensis(G7)genome:a key knowledge of parasitic platyhelminth human diseases[J].BMC Genomics,2017,18(1):204. [2] SONG X,HU D,YAN M,et al.Molecular characteristics and serodiagnostic potential of dihydrofolate reductase from Echinococcus granulosus[J].Sci Rep,2017,7(1):514. [3] 杨海山,双杰,李永臻.苯并咪唑类药物新剂型及其抗棘球蚴活性研究进展[J].中华地方病学杂志,2021,40(6):507-512. [4] 司晓妹,马俊英,张雪飞,等.细粒棘球绦虫原头蚴生长发育机制研究进展[J].热带医学杂志,2021,21(12):1622-1625. [5] SHUMUYE N A,OHIOLEI J A,GEBREMEDHIN M B,et al.A systematic review and meta-analysis on prevalence and distribution of Taenia and Echinococcus infections in Ethiopia[J].Parasit Vectors,2021,14(1):447. [6] SILES-LUCAS M,CASULLI A,CIRILLI R,et al.Progress in the pharmacological treatment of human cystic and alveolar echinococcosis:Compounds and therapeutic targets[J].PLoS Negl Trop Dis,2018,12(4):e0006422. [7] 艾斯卡·艾尼娃,阿卜杜萨拉木·艾尼,喀斯木·艾海提,等.同期联合手术治疗肝肾囊型棘球蚴病11例临床分析[J].中华普通外科杂志,2021,36(9):663-667. [8] 周文正,孙俊刚,赵喜滨,等.三维适形调强放疗对大鼠继发性股骨细粒棘球蚴原头蚴感染的疗效研究[J].中国寄生虫学与寄生虫病杂志,2021,39(4):443-448. [9] 吴戈,毛睿,张文宝,等.X射线照射后对细粒棘球绦虫原头蚴体外培养成囊率的观察[J].中国兽医学报,2019,39(12):2364-2367. [10] 毛睿. 放射治疗棘球蚴病的体内外实验研究[D].乌鲁木齐:新疆医科大学,2016. [11] LIANG G,YANG Y,NIU G,et al.Genome-wide profiling of Sus scrofa circular RNAs across nine organs and three developmental stages[J].DNA Res,2017,24(5):523-535. [12] LI D,WANG Y,WU H,et al.Mitigation of ionizing radiation-induced bone marrow suppression by p38inhibition and G-CSF administration[J].J Radiat Res,2011,52(6):712-716. [13] CANOVAS B,NEBREDA A R.Diversity and versatility of p38 kinase signalling in health and disease[J].Nat Rev Mol Cell Biol,2021,22(5):346-366. [14] BRAICU C,BUSE M,BUSUIOC C,et al.A comprehensive review on MAPK:A promising therapeutic target in cancer[J].Cancers(Basel),2019,11(10):1618. [15] FISCELLA M,ZHANG H,FAN S,et al.Wip1,a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner[J].Proc Natl Acad Sci USA,1997,94(12):6048-6053. [16] KHAN A,AHMED H,SIMSEK S,et al.Molecular characterization of human Echinococcus isolates and the first report of E.canadensis(G6/G7)and E.multilocularis from the Punjab Province of Pakistan using sequence analysis[J].BMC Infect Dis,2020,20(1):262. [17] 李涛,王玉,陈伟,等.靶向p38MAPK的siRNA通过干扰线粒体途径弱化光激发酞菁锌诱导Lovo细胞的凋亡[J].航天医学与医学工程,2016,29(4):245-249. [18] STOLL K,BERGMANN M,SPILIOTIS M,et al.A MEKK1- JNK mitogen activated kinase(MAPK)cascade module is active in Echinococcus multilocularis stem cells[J].PLoS Negl Trop Dis,2021,15(12):e0010027. [19] LÜ G,LI J,ZHANG C,et al.Molecular cloning and characterization of a p38-like mitogen-activated protein kinase from Echinococcus granulosus[J].Korean J Parasitol,2016,54(6):759-768. [20] 董晋,王禅,胡毓,等.p38丝裂原活化蛋白激酶抑制剂对肝包虫病大鼠肝功能和肝组织的影响[J].中华肝胆外科杂志,2019(12):934-936. [21] GELMEDIN V,CABALLERO-GAMIZ R,BREHM K.Characterization and inhibition of a p38-like mitogen-activated protein kinase(MAPK)from Echinococcus multilocularis:antiparasitic activities of p38MAPK inhibitors[J].Biochem Pharmacol,2008,76(9):1068-1081. [22] LV H,LI S,ZHANG J,et al.In vitro effects of SB202190 on Echinococcus granulosus[J].Korean J Parasitol,2013,51(2):255-258. [23] ZHANG C,LI J,AJI T,et al.Identification of functional MKK3/6 and MEK1/2 homologs from Echinococcus granulosus and investigation of protoscolecidal activity of mitogen-activated protein kinase signaling pathway inhibitors in vitro and in vivo[J].Antimicrob Agents Chemother,2018,63(1):e01043-18. [24] SCHIFF D,DESJARDINS A,CLOUGHESY T,et al.Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas[J].Cancer,2016,122(4):582-587. [25] WEN H,VUITTON L,TUXUN T,et al.Echinococcosis:Advances in the 21st century[J].Clin Microbiol Rev,2019,32(2):e00075-18. [26] ALVAREZ ROJAS C A,ROMIG T,LIGHTOWLERS M W.Echinococcus granulosus sensu lato genotypes infecting humans--review of current knowledge[J].Int J Parasitol,2014,44(1):9-18. [27] LARRIEU E,ZANINI F.Critical analysis of cystic echinococcosis control programs and praziquantel use in South America,1974-2010[J].Rev Panam Salud Publica,2012,31(1):81-87. [28] CUCHER M A,MACCHIAROLI N,BALDI G,et al.Cystic echinococcosis in South America:systematic review of species and genotypes of Echinococcus granulosus sensu lato in humans and natural domestic hosts[J].Trop Med Int Health,2016,21(2):166-175. [29] JENKINS D J,LIEVAART J J,BOUFANA B,et al.Echinococcus granulosus and other intestinal helminths:current status of prevalence and management in rural dogs of eastern Australia[J].Aust Vet J,2014,92(8):292-298. [30] ZHAO Y,GUI W,NIU F,et al.The MAPK Signaling pathways as a novel way in regulation and treatment of parasitic diseases[J]. Diseases,2019,7(1):9. [31] TAKEKAWA M,ADACHI M,NAKAHATA A,et al.p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38MAPK-p53 signaling in response to UV radiation[J].EMBO J,2000,19(23):6517-6526. |